Noriko Fukuhara

16PUBLICATIONS
65CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Oncology and carcinogenesis not elsewhere classifiedApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jul 24, 2026
Real-World Safety and Efficacy of Pola-R-CHP in Previously Untreated DLBCL: POLASTAR Interim Analysis of 500 Patients.

|May 20, 2026
Atezolizumab for relapsed/refractory extranodal NK/T-cell lymphoma: phase 2 of NCCH1903/ATTACK trial.

|Jan 21, 2026
Tafasitamab as Monotherapy or in Combination in Japanese Patients With B-Cell Non-Hodgkin Lymphoma: Results From the Phase 1b J-MIND Study.

Koji Izutsu, Noriko Fukuhara, Junichiro Yuda

|Jan 07, 2026
Advances in the treatment and prognosis of aggressive NK-cell leukemia: results from the ANKL22 study.

Ayumi Fujimoto, Takeshi Maeda, Noriko Doki

|Sep 02, 2025
Final results of JCOG0601 randomized trial of R-CHOP versus CHOP combined with dose-dense rituximab for diffuse large B-cell lymphoma.

Ken Ohmachi, Tomohiro Kinoshita, Dai Maruyama

|Aug 07, 2025
Diffuse Large B-Cell Lymphoma Arising in Mycosis Fungoides With Large-Cell Transformation.

Emi Yamazaki, Taku Fujimura, Yumi Kambayashi

Pageof 3

Frequent Collaborators

3 joint publications

Koji Izutsu

3 joint publications

Ritsuro Suzuki

2 joint publications

Ryo Nishikawa

2 joint publications

Momoko Nishikori